The AMP-regulated kinase family: Enigmatic targets for diabetes therapy

Molecular and Cellular Endocrinology

Volumn 297, Issue 1-2, 2009, Pages 41-49

  Rutter, Guy A ^a   Leclerc, Isabelle ^a  

^a Faculty of Medicine   (United Kingdom)

Author keywords

Diabetes; Glucose; Homeostasis; Hyperglycemia; Insulin; Kinase; Metformin; Secretion; Thiazolidenedione

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2; INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BODY WEIGHT; CELL FUNCTION; CELL SECRETION; CELL SURVIVAL; CELL TYPE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SKELETAL MUSCLE;

ADENYLATE KINASE; ANIMALS; BODY WEIGHT; DIABETES MELLITUS; HUMANS; HYPOTHALAMUS; INSULIN; INSULIN-SECRETING CELLS;

EID: 57749114540     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.05.020     Document Type: Review

References (119)

1. Alderson A., Sabelli P.A., Dickinson J.R., Cole D., Richardson M., Kreis M., Shewry P.R., and Halford N.G. Complementation of snf1, a mutation affecting global regulation of carbon metabolism in yeast, by a plant protein kinase cDNA. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8602-8605
2. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., and Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279 (2004) 12005-12008
3. Apfeld J., O'Connor G., McDonagh T., DiStefano P.S., and Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 18 (2004) 3004-3009
4. Beg Z.H., Allmann D.W., and Gibson D.M. Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol. Biochem. Biophys. Res. Commun. 54 (1973) 1362-1369
5. Beri R.K., Marley A.E., See C.G., Sopwith W.F., Aguan K., Carling D., Scott J., and Carey F. Molecular cloning, expression and chromosomal localisation of human AMP-activated protein kinase. FEBS Lett. 356 (1994) 117-121
6. Borter E., Niessen M., Zuellig R., Spinas G.A., Spielmann P., Camenisch G., and Wenger R.H. Glucose-stimulated insulin production in mice deficient for the PAS kinase PASKIN. Diabetes 56 (2007) 113-117
7. Cai Y., Martens G.A., Hinke S.A., Heimberg H., Pipeleers D., and Van de C.M. Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. Free Radic. Biol. Med. 42 (2007) 64-78
8. Carling D., Aguan K., Woods A., Verhoeven A.J., Beri R.K., Brennan C.H., Sidebottom C., Davison M.D., and Scott J. Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J. Biol. Chem. 269 (1994) 11442-11448
9. Carling D., Zammit V.A., and Hardie D.G. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 223 (1987) 217-222
10. Carlson C.A., and Kim K.H. Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J. Biol. Chem. 248 (1973) 378-380
11. Celenza J.L., and Carlson M. Cloning and genetic mapping of SNF1, a gene required for expression of glucose-repressible genes in Saccharomyces cerevisiae. Mol. Cell. Biol. 4 (1984) 49-53
12. Chavez J.A., Roach W.G., Keller S.R., Lane W.S., and Lienhard G.E. Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J. Biol. Chem. 283 (2008) 9187-9195
13. Chen Z.P., McConell G.K., Michell B.J., Snow R.J., Canny B.J., and Kemp B.E. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1202-E1206
14. Claret M., Smith M.A., Batterham R.L., Selman C., Choudhury A.I., Fryer L.G., Clements M., Al-Qassab H., Heffron H., Xu A.W., Speakman J.R., Barsh G.S., Viollet B., Vaulont S., Ashford M.L., Carling D., and Withers D.J. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 117 (2007) 2325-2336
15. Corkey B.E., Glennon M.C., Chen K.S., Deeney J.T., Matschinsky F.M., and Prentki M. A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. J. Biol. Chem. 264 (1989) 21608-21612
16. Corton J.M., Gillespie J.G., Hawley S.A., and Hardie D.G. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells?. Eur. J. Biochem. 229 (1995) 558-565
17. daSilvaXavier G., Leclerc I., Salt I.P., Doiron B., Hardie D.G., Kahn A., and Rutter G.A. Role of AMP-activated protein kinase in the regulation by glucose of islet beta-cell gene expression. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4023-4028
18. daSilvaXavier G., Leclerc I., Varadi A., Tsuboi T., Moule S.K., and Rutter G.A. Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem. J. 371 (2003) 761-774
19. daSilvaXavier G., Rutter J., and Rutter G.A. Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8319-8324
20. Daval M., Diot-Dupuy F., Bazin R., Hainault I., Viollet B., Vaulont S., Hajduch E., Ferre P., and Foufelle F. Anti-lipolytic action of AMP-activated Protein kinase in rodent adipocytes. J. Biol. Chem. (2005) 280
21. Diraison F., Leclerc I., Motakis E., Parton L., and Rutter G.A. Impact of sterol response element binding protein-1c and AMP-activated protein kinase on pancreatic islet β-cell gene expression profile. Diabetes 53 (2004) S84-S91
22. 2-sensing cells?. J. Biol. Chem. 280 (2005) 41504-41511
23. Gao S., Kinzig K.P., Aja S., Scott K.A., Keung W., Kelly S., Strynadka K., Chohnan S., Smith W.W., Tamashiro K.L., Ladenheim E.E., Ronnett G.V., Tu Y., Birnbaum M.J., Lopaschuk G.D., and Moran T.H. Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 17358-17363
24. Gleason C.E., Lu D., Witters L.A., Newgard C.B., and Birnbaum M.J. The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells. J. Biol. Chem. 282 (2007) 10341-10351
25. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J.R., Kong A., and Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
26. Gu W., Li X., Liu C., Yang J., Ye L., Tang J., Gu Y., Yang Y., Hong J., Zhang Y., Chen M., and Ning G. Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations. Endocrine 30 (2006) 217-221
27. Gu Y.Z., Hogenesch J.B., and Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 519-561 519-561
28. Hallows K.R., Kobinger G.P., Wilson J.M., Witters L.A., and Foskett J.K. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am. J. Physiol. Cell. Physiol. (2003) 284
29. Hallows K.R., McCane J.E., Kemp B.E., Witters L.A., and Foskett J.K. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J. Biol. Chem. (2003) 278
30. Hallows K.R., Raghuram V., Kemp B.E., Witters L.A., and Foskett J.K. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J. Clin. Invest. 105 (2000) 1711-1721
31. Hansen J.B., Arkhammar P.O., Bodvarsdottir T.B., and Wahl P. Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders. Curr. Med. Chem. 11 (2004) 1595-1615
32. Hao H.X., Cardon C.M., Swiatek W., Cooksey R.C., Smith T.L., Wilde J., Boudina S., Abel E.D., McClain D.A., and Rutter J. PAS kinase is required for normal cellular energy balance. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 15466-15471
33. Hardie D.G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat. Rev. Mol. Cell. Biol. 8 (2007) 774-785
34. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu. Rev. Biochem. 67 (1998) 821-855
35. Hardie D.G. Minireview: the AMP-activated protein kinase cascade-the key sensor of cellular energy status. Endocrinology 144 (2003) 5179-5183
36. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., and Hardie D.G. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2 (2003) 28
37. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., and Hardie D.G. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell. Metab. 2 (2005) 9-19
38. Hong S.P., Leiper F.C., Woods A., Carling D., and Carlson M. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 8839-8843
39. Hue L., Beauloye C., Bertrand L., Horman S., Krause U., Marsin A.S., Meisse D., Vertommen D., and Rider M.H. New targets of AMP-activated protein kinase. Biochem. Soc. Trans. 31 (2003) 213-215
40. Huypens P., Moens K., Heimberg H., Ling Z., Pipeleers D., and Van de C.M. Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells. Life Sci. 77 (2005) 1273-1282
41. Inoki K., Zhu T., and Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 (2003) 577-590
42. Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Muller O., Back W., and Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18 (1998) 38-43
43. Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y., Birnbaum M.J., and Thompson C.B. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18 (2005) 283-293
44. Kefas B.A., Cai Y., Kerckhofs K., Ling Z., Martens G., Heimberg H., Pipeleers D., and Van de Casteele M. Metformin-induced stimulation of AMP-activated protein kinase in b-cells impairs their glucose-responsiveness and can lead to apoptosis. Biochem. Pharmacol. 68 (2004) 409-416
45. Kefas B.A., Cai Y., Ling Z., Heimberg H., Hue L., Pipeleers D., and Van de C.M. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J. Mol. Endocrinol. 30 (2003) 151-161
46. Kefas B.A., Heimberg H., Vaulont S., Meisse D., Hue L., Pipeleers D., and Van de Casteele M. AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 46 (2003) 250-254
47. Kim J.W., Cho J.H., Ko S.H., Park H.S., Ha J., Song K.H., Son H.Y., Kim S.S., Yoon K.H., and Suh-Kim H. Transcriptional mechanism of suppression of insulin gene expression by AMP-activated protein kinase activator 5-amino-4-imidazolecarboxamide riboside (AICAR) in beta-cells. Biochem. Biophys. Res. Commun. 365 (2008) 614-620
48. Kola B., Boscaro M., Rutter G.A., Grossman A.B., and Korbonits M. Expanding role of AMPK in endocrinology. Trends Endocrinol. Metab. 17 (2006) 205-215
49. Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., Harvey-White J., Liposits Z., Kunos G., Grossman A.B., Fekete C., and Korbonits M. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3 (2008) e1797
50. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., and Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 (2005) 1109-1111
51. KurthKraczek E.J., Hirshman M.F., Goodyear L.J., and Winder W.W. 5′-AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48 (1999) 1667-1671
52. Leclerc I., DaSilva Xavier G., and Rutter G.A. AMP-activated protein kinase: a new-cell glucose sensor? Regulation by amino acids and calcium ions. Diabetes 53 (2004) S67-S74
53. Leclerc I., Fernadez-Millan E., Nyirenda M., and Rutter G.A. Role of AMP-activated protein kinase in glucagon secretion. Diab. Med. 24 (2007) 1
54. Leclerc I., Kahn A., and Doiron B. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett. 431 (1998) 180-184
55. Leclerc I., Woltersdorf W.W., daSilvaXavier G., Rowe R.L., Cross S.E., Korbutt G.S., Rajotte R.V., Smith R., and Rutter G.A. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E1023-E1031
56. Leclerc I., and Rutter G.A. AMP-activated protein kinase: a new beta-cell glucose sensor? Regulation by Amino Acids and Calcium Ions. Diabetes (2004) 53
57. Leclerc I., Woltersdorf W.W., da Silva Xavier G., Rowe R.L., Cross S.E., Korbutt G.S., Rajotte R.V., Smith R., and Rutter G.A. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. (2004) 286
58. Lee H., Cho J.S., Lambacher N., Lee J., Lee S.J., Lee T.H., Gartner A., and Koo H.S. The C. elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and required for resistance to oxidative stress and for normal motility and foraging behavior. J. Biol. Chem. (2008)
59. Lee J.H., Koh H., Kim M., Kim Y., Lee S.Y., Karess R.E., Lee S.H., Shong M., Kim J.M., Kim J., and Chung J. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447 (2007) 1017-1020
60. Lefebvre D.L., Bai Y., Shahmolky N., Sharma M., Poon R., Drucker D.J., and Rosen C.F. Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochem. J. 355 (2001) 297-305
61. Lefebvre D.L., and Rosen C.F. Regulation of SNARK activity in response to cellular stresses. Biochim. Biophys. Acta 1724 (2005) 71-85
62. Liang Y., Bai G., Doliba N., Buettger C., Wang L., Berner D.K., and Matschinsky F.M. Glucose metabolism and insulin release in mouse betaHC9 cells, as model for wild-type pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 270 (1996) E846-E857
63. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Makela T.P., Hardie D.G., and Alessi D.R. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23 (2004) 833-843
64. Long Y.C., and Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116 (2006) 1776-1783
65. Luo Z., Saha A.K., Xiang X., and Ruderman N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26 (2005) 69-76
66. Lupi R., Marchetti P., Giannarelli R., Coppelli A., Tellini C., Del Guerra S., Lorenzetti M., Carmellini M., Mosca F., and Navalesi R. Effects of glibenclamide and metformin (alone or in combination) on insulin release from isolated human pancreatic islets. Acta Diabetol. 34 (1997) 46-48
67. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
68. McCrimmon R.J., Shaw M., Fan X., Cheng H., Ding Y., Vella M.C., Zhou L., McNay E.C., and Sherwin R.S. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counter regulatory hormone responses to acute hypoglycemia. Diabetes 57 (2008) 444-450
69. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., and Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 (2004) 569-574
70. Minokoshi Y., and Kahn B.B. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc. Trans. 31 (2003) 196-201
71. Momcilovic M., Hong S.P., and Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 281 (2006) 25336-25343
72. Moule S.K., and Denton R.M. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439 (1998) 287-290
73. Mountjoy P.D., Bailey S.J., and Rutter G.A. Inhibition by glucose or leptin of neuropeptide Y-expressing hypothalamic neurons requires changes in AMP-activated protein kinase activity. Diabetologia 50 (2007) 168-177
74. Mountjoy P.D., and Rutter G.A. Glucose sensing by hypothalamic neurons and pancreatic islet cells: ample evidence for common mechanisms?. Exp. Physiol. 92 (2007) 311-319
75. Okamoto M., Ohara-Imaizumi M., Kubota N., Hashimoto S., Eto K., Kanno T., Kubota T., Wakui M., Nagai R., Noda M., Nagamatsu S., and Kadowaki T. Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 51 (2008) 827-835
76. Otonkoski T., Jiao H., Kaminen-Ahola N., Tapia-Piaz I., Ullah M.S., Parton L.E., Schuit F.C., Quintens R., Sipila I., Mayatepek E., Meissner T., Halestrap A.P., Rutter G.A., and Kere J. Physical exercise-induced hyperinsulinemic hypoglycemia caused by failure of monocarboxylate transporter 1 silencing in pancreatic beta cells. Am. J. Hum. Genet. 81 (2007) 467-474
77. Owen M.R., Doran E., and Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348 Pt 3 (2000) 607-614 607-614
78. Pold R., Jensen L.S., Jessen N., Buhl E.S., Schmitz O., Flyvbjerg A., Fujii N., Goodyear L.J., Gotfredsen C.F., Brand C.L., and Lund S. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54 (2005) 928-934
79. Ponting C.P., and Aravind L. PAS: a multifunctional domain family comes to light. Curr. Biol. 7 (1997) R674-R677
80. Ravnskjaer K., Boergesen M., Dalgaard L.T., and Mandrup S. Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation. J. Mol. Endocrinol. 36 (2006) 289-299
81. Riboulet-Chavey A., Diraison F., Siew L.K., Wong F.S., and Rutter G.A. Inhibition of AMP-activated protein kinase protects pancreatic {beta}-cells from cytokine-mediated apoptosis and CD8+ T cell-induced cytotoxicity. Diabetes 57 (2008) 415-423
82. Richards S.K., Parton L.E., Leclerc I., Rutter G.A., and Smith R.M. Over-expression of AMP-activated protein kinase impairs pancreatic beta-cell function in vivo. J. Endocrinol. 187 (2006) 225-235
83. Rutter G.A., daSilvaXavier G., and Leclerc I. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J. 375 (2003) 1-16
84. Rutter G.A., and Hill E.V. Insulin vesicle release: walk, kiss, pause then run. Physiology 21 (2006) 189-196
85. Rutter J., Michnoff C.H., Harper S.M., Gardner K.H., and McKnight S.L. PAS kinase: an evolutionarily conserved PAS domain-regulated serine/threonine kinase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8991-8996
86. Salt I.P., Connell J.M.C., and Gould G.W. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49 (2000) 1649-1656
87. Salt I.P., Johnson G., Ashcroft S.J., and Hardie D.G. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem. J. 335 (1998) 533-539
88. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., Hughes T.E., Groop L., Altshuler D., Almgren P., Florez J.C., Meyer J., Ardlie K., Bengtsson K., Isomaa B., Lettre G., Lindblad U., Lyon H.N., Melander O., Newton-Cheh C., Nilsson P., Orho-Melander M., Rastam L., Speliotes E.K., Taskinen M.R., Tuomi T., Guiducci C., Berglund A., Carlson J., Gianniny L., Hackett R., Hall L., Holmkvist J., Laurila E., Sjogren M., Sterner M., Surti A., Svensson M., Svensson M., Tewhey R., Blumenstiel B., Parkin M., Defelice M., Barry R., Brodeur W., Camarata J., Chia N., Fava M., Gibbons J., Handsaker B., Healy C., Nguyen K., Gates C., Sougnez C., Gage D., Nizzari M., Gabriel S.B., Chirn G.W., Ma Q., Parikh H., Richardson D., Ricke D., and Purcell S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
89. Schuit F., DeVos A., Farfari S., Moens K., Pipeleers D., Brun T., and Prentki M. Metabolic fate of glucose in purified islet cells-glucose-regulated anaplerosis in beta cells. J. Biol. Chem. 272 (1997) 18572-18579
90. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., Prokunina-Olsson L., Ding C.J., Swift A.J., Narisu N., Hu T., Pruim R., Xiao R., Li X.Y., Conneely K.N., Riebow N.L., Sprau A.G., Tong M., White P.P., Hetrick K.N., Barnhart M.W., Bark C.W., Goldstein J.L., Watkins L., Xiang F., Saramies J., Buchanan T.A., Watanabe R.M., Valle T.T., Kinnunen L., Abecasis G.R., Pugh E.W., Doheny K.F., Bergman R.N., Tuomilehto J., Collins F.S., and Boehnke M. A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
91. Sekine N., Cirulli V., Regazzi R., Brown L.J., Gine E., Tamarit-Rodriguez J., Girotti M., Marie S., MacDonald M.J., Wollheim C.B., and Rutter G.A. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cell: potential role in nutrient sensing. J. Biol. Chem. 269 (1994) 4895-4902
92. Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., and Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3329-3335
93. Shaw R.J., Lamia K.A., Vasquez D., Koo S.-H., Bardeesy N., DePinho R.A., Montminy M., and Cantley L.C. The kinase LKB1 Mediates glucose homeostasis in liver and therapeutic effects of metformin. Science (2005) 310
94. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Delisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hundson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., and Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
95. Stapleton D., Mitchelhill K.I., Gao G., Widmer J., Michell B.J., Teh T., House C.M., Fernandez C.S., Cox T., Witters L.A., and Kemp B.E. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271 (1996) 611-614
96. Sun Y., Ren M., Gao G.Q., Gong B., Xin W., Guo H., Zhang X.J., Gao L., and Zhao J.J. Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate. Acta Pharmacol. Sin. 29 (2008) 443-450
97. Targonsky E.D., Dai F., Koshkin V., Karaman G.T., Gyulkhandanyan A.V., Zhang Y., Chan C.B., and Wheeler M.B. Alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Diabetologia 49 (2006) 1587-1598
98. Townley R., and Shapiro L. Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase. Science 315 (2007) 1726-1729
99. Tsuboi T., daSilvaXavier G., Leclerc I., and Rutter G.A. 5′-AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics. J. Biol. Chem. 278 (2003) 52042-52051
100. Viollet B., Andreelli F., Jorgensen S.B., Perrin C., Flamez D., Mu J., Wojtaszewski J.F., Schuit F.C., Birnbaum M., Richter E., Burcelin R., and Vaulont S. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31 (2003) 216-219
101. Viollet B., Andreelli F., Jorgensen S.B., Perrin C., Geloen A., Flamez D., Mu J., Lenzner C., Baud O., Bennoun M., Gomas E., Nicolas G., Wojtaszewski J.F., Kahn A., Carling D., Schuit F.C., Birnbaum M.J., Richter E.A., Burcelin R., and Vaulont S. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111 (2003) 91-98
102. Wang C.-Z., Wang Y., Di A., Magnuson M.A., Ye H., Roe M.W., Nelson D.J., Bell G.I., and Philipson L.H. 5-Amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Biochem. Biophys. Res. Commun. (2005) 330
103. Wang X., Zhou L., Shao L., Qian L., Fu X., Li G., Luo T., Gu Y., Li F., Li J., Zheng S., and Luo M. Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Life Sci. 81 (2007) 160-165
104. Wilcock C., and Bailey C.J. Sites of metformin-stimulated glucose metabolism. Biochem. Pharmacol. 39 (1990) 1831-1834
105. Witters L.A., Kemp B.E., and Means A.R. Chutes and Ladders: the search for protein kinases that act on AMPK. Trends Biochem. Sci. 31 (2006) 13-16
106. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell. Metab. 2 (2005) 21-33
107. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., and Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13 (2003) 2004-2008
108. Woods A., Azzout-Marniche D., Foretz M., Stein S.C., Lemarchand P., Ferre P., Foufelle F., and Carling D. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. (2000) 20
109. Wyatt C.N., Mustard K.J., Pearson S.A., Dallas M.L., Atkinson L., Kumar P., Peers C., Hardie D.G., and Evans A.M. AMP-activated protein kinase mediates carotid body excitation by hypoxia. J. Biol. Chem. 282 (2007) 8092-8098
110. Xiao B., Heath R., Saiu P., Leiper F.C., Leone P., Jing C., Walker P.A., Haire L., Eccleston J.F., Davis C.T., Martin S.R., Carling D., and Gamblin S.J. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449 (2007) 496-500
111. Xie M., Zhang D., Dyck J.R., Li Y., Zhang H., Morishima M., Mann D.L., Taffet G.E., Baldini A., Khoury D.S., and Schneider M.D. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 17378-17383
112. Yamaguchi S., Katahira H., Ozawa S., Nakamichi Y., Tanaka T., Shimoyama T., Takahashi K., Yoshimoto K., Imaizumi M.O., Nagamatsu S., and Ishida H. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E643-E649
113. Yin W., Mu J., and Birnbaum M.J. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 278 (2003) 43074-43080
114. Yu J.G., Kruszynska Y.T., Mulford M.I., and Olefsky J.M. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Diabetes 48 (1999) 2414-2421
115. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., Timpson N.J., Perry J.R., Rayner N.W., Freathy R.M., Barrett J.C., Shields B., Morris A.P., Ellard S., Groves C.J., Harries L.W., Marchini J.L., Owen K.R., Knight B., Cardon L.R., Walker M., Hitman G.A., Morris A.D., Doney A.S., McCarthy M.I., and Hattersley A.T. Replication of genome-wide association signals in U.K. samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
116. Zhao C., Wilson C.M., Schuit F., Halestrap A.P., and Rutter G.A. Expression and distribution of lactate/monocarboxylate transporter (MCT) isoforms in pancreatic islets and the exocrine pancreas. Diabetes 50 (2001) 361-366
117. Zhao C., and Rutter G.A. Overexpression of lactate dehydrogenase A attenuates glucose-induced insulin secretion in stable MIN-6 beta-cell lines. FEBS Lett. 430 (1998) 213-216
118. Zheng B., and Cantley L.C. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 819-822
119. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174